BACKGROUND Visceral leishmaniasis is a disease caused by the protozoan Leishmania sp. and is transmitted by Lutzomyia longipalpis (sand fly). In renal transplant recipients, visceral leishmaniasis causes severe damage to the liver, spleen, and hematopoietic system, as well as poor outcomes for patients with transplanted kidneys. This study describes the largest series of cases of visceral leish...

BACKGROUND Visceral leishmaniasis is potentially fatal protozoan diseases caused by Leishmania donovani. Nepal is an endemic region in which visceral leishmaniasis causes a major public health problem in the lowland areas that border the endemic areas of Bihar state in India. Accurate diagnosis to inform treatment is a first step in achieving the goal of visceral leishmaniasis elimination from ...

Visceral leishmaniasis is a protozoar disease caused by L.donovani. Transmission to humans (incidental host) occurs via insect bite and the phlebotomous (female sand-fly) transmits the disease. Common presentations of the disease include hepatomegaly and splenomegaly, but fever, chills and night sweats may be part of the disease's symptoms. Lymphadenopathy without systemic manifestations i...

Abstract Leishmaniasis is a protozoal infection transmitted by sandfly vector; there are three main types of leishmaniasis: cutaneous leishmaniasis (CL), mucocutaneous (MCL), and visceral (VL). Herein, we present case endonasal in 34-year-old Yemeni patient who presented with disfiguring nasal swelling associated fever, swab from the lesion direct microscopic examination proved to have leishman...

BACKGROUND The early and correct diagnosis of human leishmaniasis is essential for disease treatment. Another important step in the control of visceral leishmaniasis is the identification of infected dogs, which are the main domestic reservoir of L. infantum. Recombinant proteins and synthetic peptides based on Leishmania genes have emerged as valuable targets for serodiagnosis due to their inc...

Adult-onset Still's disease (AOSD) due to visceral leishmaniasis (VL) has not been previously reported. This case report analyzes a single episode of AOSD probably due to a visceral leishmaniasis successfully treated with pentamidine isethionate and prednisone.

Leishmaniasis is a vector-borne neglected tropical disease associated with a spectrum of clinical manifestations, ranging from self-healing cutaneous lesions to fatal visceral infections. Among the most important questions in Leishmania research is why some species like L. donovani infect visceral organs, whereas other species like L. major remain in the skin. The determinants of visceral leish...

BACKGROUND The number of leishmaniasis cases associated with immunosuppression has increased regularly over the past 20 years. Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases the risk for Leishmania-infected people to develop visceral illness. CASE PRESENTATION Three cases of Leishmania infantum leishmaniasis in...

This study aimed to demonstrate the geographical expansion of visceral leishmaniasis in Pernambuco State, Brazil. With data on the number of visceral leishmaniasis cases notified from 1990 to 2001, maps showing the biannual evolution of the geographical distribution of the disease per municipality were elaborated. A map of the cumulative geographical distribution of the cases registered during ...

Visceral leishmaniasis is a macrophage associated disorder which leads to a profound decrease in the natural immunotherapeutic potential of the infected subjects to combat the disease. The major surface glycoprotein gp63 has been found to be a significant vaccine candidate against visceral leishmaniasis. The current study addresses the levels of similarity and identity in the gp63 obtained from...